Arsenic exposure during embryonic development can cause ischemic heart pathologies later in adulthood which may originate from impairment in proper blood vessel formation. The arsenic-associated detrimental effects are mediated by arsenite (iAs III ) and its most toxic metabolite, monomethylarsonous acid [MMA (III)]. The impact of MMA (III) on coronary artery development has not yet been studied. The key cellular process that regulates coronary vessel development is the epithelial-mesenchymal transition (EMT). During cardiac EMT, activated epicardial progenitor cells transform to mesenchymal cells to form the cellular components of coronary vessels. Smad2/3 mediated TGF␤2 signaling, the key regulator of cardiac EMT, is disrupted by arsenite exposure. In this study, we compared the cardiac toxicity of MMA (III) with arsenite. Epicardial progenitor cells are 15 times more sensitive to MMA (III) cytotoxicity when compared with arsenite. MMA (III) caused a significant blockage in epicardial cellular transformation and invasion at doses 10 times lower than arsenite. Key EMT genes including TGF␤ ligands, T␤RIII, Has2, CD44, Snail1, TBX18, and MMP2 were down regulated by MMA (III) exposure. MMA (III) disrupted Smad2/3 activation at a dose 20 times lower than arsenite. Both arsenite and MMA (III) significantly inhibited Erk1/2 and Erk5 phosphorylation. Nuclear translocation of Smad2/3 and Erk5 was also blocked by arsenical exposure. However, p38 activation, as well as smooth muscle differentiation, was refractory to the inhibition by the arsenicals. Collectively, these findings revealed that MMA (III) is a selective disruptor of cardiac EMT and as such may predispose to arsenic-associated cardiovascular disorders.
influences due to environmental arsenic in this disease process are unknown. Similarly, the impact of toxicants on blood vessel formation and function during development has not been well characterized.
After absorption into the body, arsenate (AsV) is first reduced to arsenite (AsIII), then methylated by arsenic(+3)-methyltransferase (AS3MT) to form metabolites that include monomethylarsonous acid (MMA) and dimethylarsonous acid (DMA), which are excreted in the urine (Meza et al., 2004) . Although methylation of inorganic arsenic facilitates excretion and is considered to be a detoxification mechanism, highly reactive intermediate MMA (III) has been reported to induce severe cytotoxicity in hepatocytes (Petrick et al., 2000) . Elevated MMA (III) levels in the urine and tissues also lead to a higher risk of arsenic-associated skin lesions (Yu et al., 2000) . During pregnancy, arsenic and its metabolites can easily pass through the placenta to the fetus. Compared with the later stages of life, the fetus is exposed to relatively higher level of arsenic and MMA (III) during early gestation as a result of the insufficient methylation of transferred inorganic arsenic (Vahter, 2009 ). However, the potential adverse effects caused by MMA (III) on fetal growth and especially on the development of the cardiovascular system have not been studied.
Coronary artery development begins with a portion of cardiac progenitor cells derived from the epicardium undergoing an epithelial-mesenchymal transition (EMT). These cells transform into fibroblast-like mesenchyme, migrate and invade the myocardium, and differentiate into several cardiac cell types including smooth muscle cells and endothelial cells, which comprise cellular components of coronary vessels (Austin et al., 2008) . We previously demonstrated that the TGF␤ ligands, especially TGF␤2, are key inducers of developmental cardiac EMT in mice (Camenisch et al., 2002) . The canonical TGF␤2 pathway is mediated by phosphorylated Smad2/3 effectors which translocate to the nucleus and regulate the expression of genes that determine cell differentiation and extracellular matrix remodeling (Allison et al., 2013; Kurisaki et al., 2001) . Smads are not the only downstream effectors of TGF␤2; Smad-independent non-canonical pathways such as the mitogen-activated protein kinase (MAPK) pathway also participate in TGF␤ signaling. Smad3 activation is required but not sufficient to induce TGF␤-mediated EMT, indicating a co-regulation of non-canonical effectors (Itoh et al., 2003; Yu et al., 2002) . The MAPKs and Erk5 are also required for the disassembly of cell adherens junctions and induction of cell motility mediated by TGF␤, as its activation regulates a subset of target genes that regulate cell-matrix interactions, cell motility, and endocytosis (Gui et al., 2012) . We have previously reported that low level arsenic exposure disrupted canonical TGF␤2 signaling via reduced Smad2/3 phosphorylation and nuclear translocation (Allison et al., 2013) . Here we investigate the impact of MMA (III) on TGF␤2 mediated EMT during early events critical for coronary vessel development. Our observations suggest that low level arsenical exposure selectively disrupts non-canonical MAPK in addition to blocking canonical Smad2/3 activation during cardiac EMT. However, differentiation into smooth muscle is refractory to the effects of MMA (III) exposure.
MATERIALS AND METHODS
Cell line and cell culture. Conditionally immortalized epicardial cells were harvested and cultured as previously described (Austin et al., 2008) . Briefly, epicardial progenitor cells were generated from transgenic mice that carried a temperature sensitive promoter driven SV40 large T antigen. For experiments, epicardial cells were moved to 37
• C condition, where the thermolabile promoter of SV40 antigen was silenced reverting cells to a primary cell state. Complete cell culture Dulbecco's modified Eagle's medium media containing 10% fetal bovine serum, antibiotics, insulin-transferrin-selenium (Invitrogen, Carlsbad, CA), and mouse gamma interferon (10 U/ml, R&D systems, Minneapolis, MN) was used to maintain cells.
MTS cell viability assay. Cells at 80% confluence were serum starved for 6 h followed by exposure to indicated doses of arsenite or MMA (III) for 24 or 48 h. Cell viability was assessed based on relative mitochondrial activity which was measured by the tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS] (Promega G5421). The absorbance of the bioreduced MTS was detected at 490 nm in an M2 Spretramax plate reader (Molecular Devices). Cell viability analysis and calculation of IC 50 values were described previously (Allison et al., 2013) . All assays were performed in triplicate at each concentration of arsenite or MMA (III) in a minimum of three independent determinations. Statistical significance was determined by two-tailed Student's t-test.
Real-time PCR. 80% confluent cells were serum starved for 6 h before exposure to arsenite or MMA (III) for 24 h. Total RNA was extracted using the RNA-STAT60 reagent following the manufacturer's instructions (Tel-test, Invitrogen). cDNA was synthesized using the Transcriptor First Strand cDNA Synthesis Kit (Roche Applied Science). Real-time PCR was performed using TaqMan Master primer-probe system (Roche). The housekeeping gene 40S Ribosomal Protein 7 (RPS7) was used as an internal calibrator control for gene expression analysis. Heme oxygenase 1 (Hmox1) was used as a positive control as it responds to arsenite induced oxidative stress. The following TaqMan primers were designed to detect the indicated genes:
Western blot analysis. Serum starved cells were exposed to arsenite or MMA (III) for 24 h followed by TGF␤2 stimulation for the indicated time periods. Whole cell protein lysates were prepared in RIPA buffer containing 10mM sodium phosphate (pH 8.0), 150mM sodium chloride, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS) (Lau et al., 2010) . Protease inhibitor and phosphatase inhibitors (phenylmethylsulfonyl fluoride, sodium fluoride (NaF), and vanadate at 1M final concentration) were added into RIPA buffer. To detect nuclear expression of selected proteins, nuclear fractionation of protein lysates was performed as previously described (Haspel and Darnell, 1999) . Cell lysates or nuclear fractionations were resolved by 10% SDS-PAGE and transferred to 0.45 m nitrocellulose membrane. The membranes were blocked with 5% BSA/TBST and then incubated with different antibodies diluted in 3% BSA/TBST (1:000 dilution for all primary antibodies and 1:3000 dilution for all secondary antibodies). Immunoblotting detection was performed using chemiluminescence reagent (100mM Tris pH 8.5, 250mM luminol, 92mM p-coumaric acid, and 0.018% H 2 O 2 ) as previously described (Sollome et al., 2014 Collagen gel invasion assay. In order to determine the detrimental effects of arsenicals on epicardial cell invasion, fluorescently labeled cells were placed onto collagen gels casted in the upper chamber of a transwell 96-well plate. Cells were then given 1.34M arsenite or 0.134M MMA (III) with 2 ng/ml TGF␤2 for 48 h. The extent of cellular invasion was quantified by detecting fluorescent signals in the lower chamber of the transwell system as previously reported (Craig et al., 2009) . Detection of specific fluorescence was determined at 538 nm using a Spectramax Gemini plate reader (Molecular Devices, Sunnyvale, CA).
Immunostaining. An equal number of epicardial cells were seeded on Rat Tail Type I Collagen gels (BD Biosciences, Franklin Lakes, NJ) within a glass cylinder to set up culture for the EMTcollagen gel assay. After epicardial cells formed a monolayer with a defined cell edge on the gel surface, they were subjected to the indicated conditions. Cells on collagen gels were fixed in 4% PFA at room temperature for 15 min. Fixed cells were then permeabilized with 0.5% Triton X-100/PBS for 10 min followed by rinsing with 1× PBS for 5 min. Cells were blocked in 5% BSA/PBS for 2 h at room temperature and incubated with ␤-catenin primary antibody (sc-31001, Santa Cruz Biotechnology) in 1:100 dilution at 4
• C overnight. Cells were subjected to six washes in 1× PBS, and primary antibody was detected with a 1:500 dilution of goat anti-rabbit secondary antibody (Jackson ImmunoResearch, West Grove, PA). Cells were then subjected to six washes followed by nuclei staining, using 4,6-diamidino-2-phenylindole (DAPI; Sigma), for 30 min at room temperature. Collagen gels were mounted on glass slides and the morphology of epicardial cells was detected by ␤-catenin staining and distribution. Fluorescence microscopy was performed using a Leica DMLB microscope and documented using a Retiga 200R camera and ImagePro Plus 5.1 software.
SM22␣ reporter assay.
Epicardial cells isolated from SM22␣-LacZ reporter transgenic mice were generated and isolated as described (Compton et al., 2007) . This cell line has been established as a cellular model to determine epicardial cell differentiation into a smooth muscle cell lineage in vitro. SM22␣-LacZ epicardial cells were pre-exposed with arsenite or MMA (III) for 18 h and subsequently stimulated with 2 ng/ml TGF␤2 for 24 h to allow transformation. X-GAL staining was performed using the ␤-galactosidase reporter gene staining kit (Sigma-Aldrich) to detect SM22␣ promoter activity. Relative expression of SM22␣ reporter gene was detected by real-time PCR by standard methods and primers illustrated in Table 1 .
RESULT

MMA (III) Exhibits Higher Cytotoxicity on Epicardial Cells Compared with Arsenite
Monomethylarsonous acid [MMA (III)] is a toxic arsenic species that is generated during arsenite metabolism. The toxicity of MMA (III) on epicardial progenitor cells is not known. We investigated epicardial cell viability exposed to arsenite or MMA (III) at 24 and 48 h. The ranges of concentrations studied were from 0 to 20M for sodium arsenite and 0 to 1.2M for MMA (III). Figure  1 shows arsenite impairing cell viability starting at 3M after exposure with an IC 50 value of 11.8M at 24 h and an IC 50 of 7.8M at 48 h. This is consistent with a previous report on arsenic toxicity on epicardial cells (Allison et al., 2013) . We detect higher sensitivity to MMA (III) exposure by epicardial cells compared with the parent compound arsenite. We found the IC 50 value for MMA (III) cytotoxicity at 24 h to be 0.6M, and the IC 50 at 48 h to be 0.5M. These results show that epicardial cells are approximately 15 times more sensitive to MMA (III) induced cytotoxicity compared with arsenite.
Arsenicals Block the Expression of Key Genes that Regulate Developmental EMT
We have previously reported that arsenite disrupts some of the key genes that regulate EMT in a dose-dependent manner (Allison et al., 2013) ; however, the role of MMA (III) in regulating EMT gene expression is not known. We examined a representative panel of EMT-related genes. The TGF␤ family of molecules, including the TGF␤ ligands TGF␤1 and TGF␤2, and the key ligand presenting receptor T␤RIII, are known to function in cell differentiation and invasion during organogenesis (Compton et al., 2007) . Has2, which is the major enzyme that synthesizes hyaluronan, and its receptor CD44 have been previously reported to stimulate epicardial cell invasion (Craig et al., 2010) . The TGF␤ effector Snail1 is an essential transcription factor that induces EMT in both developmental and cancer models (Medici et al., 2008; Tran et al., 2011) . The T-Box factor, TBX18, and Matrix Metalloproteinases, MMP2, also function in developmental 
EMT (Duong and Erickson, 2004; Keichi et al., 2013) . Vascular endothelial growth factor (VEGF) has been identified as an inhibitor of developmental EMT as previously reported by our laboratory (Dor et al., 2003) . Also, because increased expression of Hmox1 is associated with the response to arsenic exposure, Hmox1 was used as a positive control in the gene expression analysis (Allison et al., 2013) . The effects of MMA (III) exposure on the expression of the EMT programmed genes were observed 24 h after exposure, and 1.34M arsenite was used as a control for comparison. These concentrations were used because they are below the IC 50 concentrations, respectively. As shown in Figure 2 , both arsenicals significantly inhibit the expression of TGF␤ ligands, T␤RIII, Has2, CD44, as well as Snail1, TBX18, and MMP2. MMA (III) exhibited a similar inhibitory effect in a much lower dose compared with arsenite exposure. In contrast, we detect an induction in VEGF expression consistent with its role in downregulating EMT. Collectively, we detect a dramatic reduction in the pro-EMT gene program following exposure to MMA (III) with a concurrent substantial increase in VEGF, a negative regulator of EMT.
MMA (III) Inhibits TGF␤2-Induced N-Cadherin Expression and Cellular
Invasion N-cadherin is a cell adhesion molecule known to increase with TGF␤ stimulation. However, the expression of N-cadherin in response to TGF␤2 stimulation during epicardial EMT and the regulatory effect of arsenicals on it have not been elucidated. To address this question, we treated epicardial cells with 2 ng/ml TGF␤2 in the presence or absence of arsenite or MMA (III) for 48 h. As shown in Figure 3A , TGF␤2 induces a dramatic increase in N-cadherin detection (Fig. 3A , lane 2) compared with control. In contrast, N-cadherin is substantially reduced following arsenite and MMA (III) exposure (Fig. 3A, lanes 3 and 4) . MMA (III) decreased N-cadherin expression more profoundly than arsenite. Also, MMA (III) and arsenite decrease N-cadherin basal protein level compared with untreated group (Fig. 3A , lanes 5 and 6), indicating that arsenicals were able to block endogenous growth factors induced N-cadherin expression without affecting epicardial cellular viability. To determine if N-cadherin expression correlates with less mesenchymal cell production, invasive cell motility was detected in the presence or absence of MMA (III) (Fig. 3B ). TGF␤2 stimulates cellular invasion by 40% in the modified Boyden chamber assay, whereas arsenite and MMA (III) exposure during TGF␤2 stimulation ablates this invasive cell motility. Arsenite or MMA (III) alone had no effect on the basal level of cell motility. In order to visualize cell morphology of transforming epicardial cell under each condition, spot culture assays were performed as previously described (Allison et al., 2013) . Epicardial cell monolayers with a defined cell boundary were exposed to arsenicals in the presence or absence of TGF␤2. As shown in Figure 3C , epicardial cells were activated and transformed into fibroblast like mesenchymal cells following TGF␤2 stimulation. In contrast, arsenical exposure profoundly blocked cell transformation as less transformed cells were observed.
The change in mesenchymal cell numbers between groups was quantified as shown in Figure 3D . TGF␤2 induced a 10-fold increase in mesenchymal cell production compared with control which was almost completely blocked by arsenical exposure. Thus, MMA (III) is a highly potent arsenical species that silences developmental cardiac EMT.
Smooth Muscle Differentiation is Refractory to MMA (III) Toxicity
We previously detected that arsenite exposure does not affect TGF␤2-induced smooth muscle differentiation in epicardial cells (Allison et al., 2013) . Because epicardial cells do not metabolize arsenite, experiments were performed to determine the impact of MMA (III) on smooth muscle cell differentiation. Smooth muscle actin 22␣ is a marker for differentiated vascular smooth muscle cells (Compton et al., 2006) . SM22␣-LacZ epicardial cells derived from transgenic mice were exposed to 1.34M arsenite or 0.134M MMA (III) for 18 h followed by TGF␤2 stimulation for 24 h. ␤-Galactosidase staining was used to detect the expression of LacZ. As shown in Figure 4A , TGF␤2 induces a dramatic expression of ␤-galactosidase which indicates activation of SM22␣ promoter and the smooth muscle cell phenotype. This induction is not abrogated by MMA (III) exposure. To further assess SM22␣ promoter activity, real-time PCR analysis for SM22␣ reporter mRNA was performed. As shown in Figure 4B , TGF␤2 induced SM22␣ gene mRNA and this expression was not blocked by arsenicals exposure indicating that smooth muscle differentiation is refractory to the effects of arsenicals.
Arsenite and MMA (III) Block Smad2/3, Erk1/2, and Erk5 Phosphorylation, But not p38 Phosphorylation
The activation of the TGF␤ pathway leads to phosphorylation of downstream canonical and non-canonical effectors. We have previously reported that arsenite blocks the Smad2/3-dependent TGF␤2 canonical pathway (Allison et al., 2013) . Erk1/2, Erk5, and p38 MAPKs are involved in TGF␤2-induced EMT in tumor models (de la Cruz-Merino et al., 2009; Dreesen and Brivanlou, 2007) . In order to investigate whether these noncanonical MAPK cascades respond to TGF␤2 stimulation compared with canonical Smad2/3 in epicardial cells, a time course following TGF␤2 stimulation was performed to detect phosphorylation of Erk5, Erk1/2, and p38. As shown in Figure 5A , Smad2/3 and Erk5 respond to TGF␤2 stimulation in a similar manner. Detection of phosphorylated Smad2/3, and Erk5 starts at 10 min after TGF␤2 stimulation, and the phosphorylation level persists with the presence of TGF␤2. Duration of Erk1/2 activation is fast and short which only occurs within the first 5 min upon TGF␤2 stimulation. In contrast, p38 responds to TGF␤2 in a biphasic manner. A quick induction is detected at 1 min after TGF␤2 stimulation, this phosphorylation disappears and is detected again at 30 min and persists out to 1 h. The detection of the phosphorylation pattern of Erk1/2, Erk5, and p38 following TGF␤2 stimulation allows for the determination of the effects of arsenicals on their activation. Epicardial cells were pre-exposed to 1.34M arsenite, 0.07M, or 0.13M MMA (III) for 24 h. Each condition was then stimulated with TGF␤2 and compared with untreated controls. As shown in Figure 5B , a 20-fold lower concentration of MMA (III) blocked the phosphorylation of Smad2/3. Both arsenite and MMA (III) decreased TGF␤2-induced activation of Erk1/2 and Erk5. However, the activation of p38 appears to be refractory to this inhibition by MMA (III) and arsenite.
Arsenicals Selectively Block Smad2/3 and Erk5 Nuclear Translocation
To determine whether the blockage in activation of Smad2/3 and Erk5 leads to decreased nuclear localization, we performed parallel experiments as described in Figure 5 , and prepared lysates from nuclear fractionations for the detection of Smad2/3, Erk5, and p38. As shown in Figure 6 , TGF␤2 induced an increase in Smad2/3 and Erk5 nuclear localization (Fig. 6, lane 2) ; however, arsenicals dramatically block this event (Fig. 6 , lanes 3, 4, and 5). MMA (III) exhibited the same inhibitory effect as arsenite but at a much lower concentration, and in a dose-dependent manner (Fig. 6 , lanes 4 and 5). Both arsenite and MMA (III) showed no effect on p38 nuclear translocation.
DISCUSSION
Chronic arsenic exposure through contaminated water has been linked to ailments in adults (Abernathy et al., 1999; Naujokas et al., 2013) . Incidence of spontaneous abortion, low birth weight, and fetal malformations associated with arsenic exposure during pregnancy suggests that arsenic also has developmental toxicity (Aggarwal et al., 2007; Farzan et al., 2013) . Methylation of inorganic arsenic has been considered a major metabolic mechanism to convert arsenic into more readily excretable forms; however, it is not always a detoxification process. Studies have shown that mono-methylated arsenic, especially the trivalent form, MMA (III), elicits higher cytotoxicity and is a more active carcinogen compared with the parent form of arsenic (Petrick et al., 2000; Steinmaus et al., 2006; Yu et al., 2000) . MMA (III) induces malignant transformation of urothelial cells (UROtsa), a well-established cell model for studying bladder cancer, at concentrations 20-fold less than arsenite (iAs III ) (Medeiros et al., 2012) . Similarly, we detect the cytotoxic IC 50 value of MMA (III) to be 20 times lower compared with the IC 50 value of As III (at 24 h).
Although an increase in cell cytotoxicity is seen with the longer arsenite exposure at 48 h, MMA (III) elicits higher toxicity by 24 h. This indicates that MMA (III) is a potent and cytotoxic agent (Fig. 1) . Arsenic-related toxicity through MMA (III) has drawn increased interest in an effort to understand its detrimental effects (Ge et al., 2013; Rahman and Hassler, 2014) . Due to kidney filtration, the bladder is the primary exposure site for accumulated MMA (III). The mechanism of MMA (III) in triggering malignant urothelial transformation during bladder cancer has been well studied (Medeiros et al., 2012; Wang et al., 2007; Wnek et al., 2010) . There is limited data showing how MMA (III) potentiates skin cancer (Chen et al., 2008; Delker et al., 2009) , or the role of MMA (III) in other arsenic induced diseases. One report on nanomolar levels of MMA (III) impairing vascular smooth muscle contractility in mice suggests that MMA (III) contributes to arsenicassociated cardiovascular diseases more potently than arsenite
FIG. 4. Smooth muscle differentiation is not blocked by MMA (III)
. Transgenic smooth muscle 22␣-LacZ epicardial cells were left untreated or pretreated with 1.34 M NaAsO2 or 0.13 M MMA (III) for 18 h followed by co-treatment with 2 ng/ml TGF␤2 for 48 h. X-gal staining was applied on fixed cells to detect the SM22␣ LacZ activity (A). mRNA gene expression of smooth muscle 22␣ (SM22␣) was measured and normalized to RPS7, *=pϽ0.05, NS=pϾ0.05 (B).
FIG. 5.
Arsenicals block TGF␤2 induced phosphorylation of Smad2/3 and Erk1/2 and Erk5 but not p38. Epicardial cells were stimulated with 3 ng/ml TGF␤2 for 0-60 mins. Whole cell lysates were subjected to immunoblotting analysis (A). Epicardial cells were either left untreated or pre-treated with 1.34 M NaAsO2, 0.067 M MMA (III), or 0.13 M MMA (III) for 24 h and subsequently stimulated with 3 ng/ml TGF␤2 (15 min for Smad and Erk5 activation, 2 min for Erk1/2 and p-p38 activation). Whole cell lysates were subjected to immunoblotting with antibodies against phosphorylated and total forms of Smad2/3, Erk1/2, Erk5, and p38 as well as ␤-actin (B).
FIG. 6.
Arsenicals selectively block Smad2/3 and Erk5 nuclear translocation. Epicardial cells were exposed to the indicated doses of NaAsO2 or MMA (III) for 24 hours followed with or without 3 ng/ml TGF␤2 stimulation (20 min for Smad2/3 and Erk5 nuclear translocation, 45 min for p38 nuclear translocation). Nuclear fractionations were subjected to western blotting with antibodies against Smad2/3, Erk5, p38, and LaminA. Although whole cellular p-Erk5 is modestly reduced, detection of nuclear Erk5 is dramatically decreased in MMA (III) exposed samples (A). Densitometry analysis of Smad2/3/LaminA, Erk5/LaminA, and p38/LaminA were performed. Relative densities of targets bands in 1.34 M As + TGF␤2, 0.067 M MMA (III) + TGF␤2, 0.13 M MMA (III) + TGF␤2 groups were compared to the 3 ng/ml TGF␤2 group. Data were analyzed from 3 independent experiments using a two tail Student's t-test. *=pϽ0.01, NS=pϾ0.36. (B). (Bae et al., 2008) . Both inorganic arsenic and MMA pass through the placental membrane, and embryonic progenitor cells are much more sensitive than terminally differentiated adult cells (Allison et al., 2013; Jin et al., 2006) . However, the developmental toxicity of MMA (III) has not been extensively investigated. We show here that MMA (III) inhibits coronary progenitor cell EMT, which may lead to altered coronary vasculature during fetal development. Exposure to MMA (III) at substantially lower levels than arsenite causes significant decrease in production of invasive mesenchyme by TGF␤ stimulation. Canonical Smad activation triggered by TGF␤2 is blocked by MMA (III) exposure. Erk1/2 as well as Erk5 MAP kinase activation, which compromise noncanonical TGF␤2 signaling, are also affected by both arsenite and MMA (III). However, MMA (III) has no impact on cardiac smooth muscle differentiation, or p38 signaling, as both remain intact despite arsenite or MMA (III) exposure. This suggests that arsenicals do not uniformly disrupt signaling cascades associated with developmental EMT.
EMT is a cellular process where epithelial cells lose cell polarity and adhesion to basement membrane to gain migratory and invasive properties of mesenchymal cells which can differentiate into multiple cell types (Austin et al., 2008; Carew et al., 2012; Compton et al., 2006) . EMT plays an essential role in embryogenesis, tissue repair and regeneration, fibrosis, and cancer metastasis (Galichon and Hertig, 2011; Janda et al., 2002; Kalluri and Weinberg, 2009) . EMT is classified into three subtypes based on the stimuli and context (Carew et al., 2012) . Type 1 EMT, also referred as developmental EMT, occurs during early embryogenesis. In heart development, endocardial EMT contributes to endocardial cushion development and valve formation, whereas epicardial EMT contributes to coronary vessel development and valve remodeling (Allison et al., 2013; Azhar et al., 2011; Lencinas et al., 2013) . Type II and type III EMT occur during adulthood contributing to tissue fibrosis and cancer (Carew et al., 2012) . Arsenicals can induce fibrosis and cancer in multiple cell lines and animal models, indicating a contribution to detrimental type II and type III EMT; however, the role of arsenicals in type I developmental EMT remains poorly understood (Ghatak et al., 2011; Sarin et al., 1999; Wang et al., 2013; Xu et al., 2012b) . We investigated MMA (III) effects on a comprehensive set of type I EMT genes (Fig. 2) . There is a profound inhibition in the mRNA expression of TGF␤2 and T␤RIII with MMA (III) (0.13M) exposure when compared with the changes in TGF␤1, T␤RI, and T␤RII. T␤RIII serves a distinct role in amplifying TGF␤2 downstream signaling by inducing high affinity binding between TGF␤2 and T␤RI and T␤RII (Compton et al., 2007) . These results suggest that TGF␤2 is a sensitive target to arsenical toxicity, which is consistent with the previous report that TGF␤2, instead of TGF␤1 and TGF␤3, is the key inducer of developmental EMT during early embryogenesis (Camenisch et al., 2002; Doetschman et al., 2012) .
The expression of Snail1, a downstream effector of TGF␤ signals, is also decreased with MMA (III) exposure indicating an inhibitory effect on TGF␤ signaling. This coincides with the significant down-regulation in the protein level of N-cadherin (Fig. 3A) , which normally increases during cell differentiation and mesenchymal production (Avdal et al., 2007; Nakajima et al., 2004) . Disruption in extracellular matrix signaling also occurs with MMA (III) exposure, shown by a decreased mRNA level of Has2 and MMP2. This coincides with less activated epicardial cells and a decrease in invasive mesenchyme as detected by the invasion assays (Fig. 3B-D) . Hmox1 is a transcriptional factor that can be activated by cellular oxidative stress (Xin et al., 2014; Yan et al., 2014) . The fact that Hmox1 is poorly induced by MMA (III) when compared with arsenite suggests that although MMA (III) is more cytotoxic, it may induce less reactive oxygen species mediated cellular stress.
Mesenchymal cells produced from activated epicardial cells can invade the myocardium and give rise to smooth muscle cells and form coronary vessels (Compton et al., 2006; Darland and D'Amore, 2001) . Although smooth muscle differentiation occurs after EMT, it does not mean that it is regulated by EMT, or that it requires the same regulation as the EMT process. We showed that arsenite has no inhibitory effects on TGF␤2-induced smooth muscle differentiation in epicardial progenitors (Allison et al., 2013) . In this study, MMA (III) also does not block smooth muscle differentiation; however it strongly inhibits EMT (Fig. 4) . These observations indicate that there is divergence in the signaling pathways involved in EMT and smooth muscle differentiation processes, and that EMT-regulated pathways are selectively inhibited by arsenicals. Other studies have shown similar observation that activation of RhoA and p160 rho kinase is required to induce expression of smooth muscle markers SM22␣ and SM␣A (Compton et al., 2006; Lu et al., 2001; Mack et al., 2001) . However, there are conflicting results on the role of p38 in the differentiation of smooth muscle. Stimulation of p38 activity was shown to be associated with smooth muscle de-differentiation and decreased expression of smooth muscle markers (Hayashi et al., 1999 (Hayashi et al., , 2001 . However, other studies report that p38 activation increases SM␣A expression (Compton et al., 2006) . In the present study, we show p38 activation in response to TGF␤2 stimulation. This activation and nuclear translocation is not affected by arsenical exposure (Figs. 5 and  6 ). Together, we show that cellular events and signaling pathways that are related to smooth muscle differentiation remain intact despite arsenical exposure.
The disruption of TGF␤2 signaling in cardiac EMT is caused by down-regulation of its intracellular effectors, Smad2/3. We have previously reported that low level arsenite exposure significantly blocks phosphorylation and nuclear translocation of Smad2/3 (Allison et al., 2013) . Here, we observe the same inhibitory effects with MMA (III) at much lower concentration (0.067M and 0.13M) (Fig. 5B ). Smad2/3 are key transcriptional factors that mediate TGF␤2 stimulation (Gaarenstroom and Hill, 2014) . Activation of Smad3 is detected in TGF␤-mediated fibrosis in heart and kidney (Divakaran et al., 2009; Qin et al., 2011) . Smad2 activity is required to modulate self-renewal and differentiation of mouse embryonic stem cells (Xu et al., 2012a) . On the other hand, overexpression of Smad3 fails to fully induce TGF␤2 mediated EMT, indicating that other non-canonical Smad pathways are also required for diverse cellular events (Townsend et al., 2011) .
MAPK activation is part of the non-canonical signaling triggered by TGF␤ (Craig et al., 2008; Zhang, 2009) . Stimulated T␤RI and T␤RII recruit and activate the Shc/Grb2/Sos complex. This complex then activates Ras to consequently phosphorylate MAP3K (Raf) which then activates MAP2K (MEK), and eventually active MAPKs (Erk1/2) (Zhang, 2009) . Previous work reported that the MAP3K, MEKK3, contributes to cardiac EMT via activation Erk1/2 and Erk5, in response to TGF␤2 (Craig et al., 2010) . ERK5 null embryos have deficits in vessel development and heart looping (Regan et al., 2002) , and overexpression of Erk1/2 promotes segregation during development of vasculogenesis (Kim et al., 2013) . Both Erk1/2 and Erk5 activity are required to mediate TGF␤2-induced hyaluronic acid production and cell differentiation during cardiac EMT (Craig et al., 2010) . Erk5 and p38 kinases also translocate into the nucleus to modulate the activity of other related transcription factors and chromatin remodeling enzymes (Craig et al., 2008) . In addition, unlike Erk5, Erk1/2 do not have subcellular preference upon stimulation with TGF␤2 (Supplementary fig. 1A ). In this study, phosphorylation of Erk1/2 and Erk5 MAPK is inhibited by arsenite and MMA (III) exposure (Fig. 4B) . Furthermore, Erk5 nuclear translocation is also dramatically blocked by arsenite and MMA (III) exposure (Fig. 5) . Although no clear evidence shows that nuclear expression of Erk5 is required for its signaling transduction, it is possible that nuclear localization may facilitate Erk5 kinase activity in activating other transcriptional factors to regulate gene expression during cardiac EMT.
Collectively, these data demonstrate that MMA (III) exhibits developmental toxicity on select EMT signaling pathways. Down-regulation of TGF␤2, T␤RIII, Snail1, MMP2, as well as inhibition of Smad2/3, Erk1/2, and Erk5, suggests that these are sensitive targets to environmental insults during cardiac EMT. Activation of these pathways not only contributes to early embryonic development, but is also required to promote cardiac regeneration after injury during adulthood. In addition, we also show that both activation of p38 and smooth muscle differentiation are refractory to effects of arsenical exposure. In conclusion, disruptions in canonical Smad2/3 and non-canonical Erk1/2 and Erk5 signaling are mechanisms for MMA (III) inhibition of developmental cardiac EMT.
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